SlideShare a Scribd company logo
January,	
  2008	
  June,	
  2007	
  
From anecdote …
… to evidence
GTF.CCC
Members	
  
GTF.CCC:
Mission and Vision
•  design, participate in implementation, and
evaluate innovative strategies for expanding
access to cancer prevention, detection and care
that provide local and cross-country evidence for
scaling up access to cancer care and control, and
strengthening health systems in LMICs.
•  facilitate action through the production of new
knowledge and through multi-stakeholder
frameworks and partnerships that demonstrate
effective models of care that can be replicated and
scaled up in LMICs.
= global health + cancer care
Abish Romeo,
México
Drew G. Faust
President of Harvard University
22+ year BC survivor
Closing the Cancer Divide:
An Equity Imperative
I: Should be done
II: Could be done
III: Can be done
M1. Unnecessary
M2. Unaffordable
M3. Impossible
M4: Inappropriate
Expanding access to cancer care and control in LMICs:
1: Innovative Delivery
2: Access: Affordable Med’s, Vaccines & Tech’s
3: Innovative Financing: Domestic and Global
4: Evidence for Decision-Making
5: Stewardship and Leadership
Cancer is a disease of both rich and poor but
the poor suffer even more:
1.  Exposure to risk factors
2.  Preventable cancers (infection)
3.  Treatable cancer death and disability
4.  Stigma and discrimination
5.  Avoidable pain and suffering
Closing the Cancer Divide
is an Equity Imperative
Facets
Adults
Leukaemia
All cancers
Source: Knaul, Arreola, Mendez. estimates based on IARC, Globocan, 2010.
Children
LOW
INCOME
HIGH
INCOME
Survival
inequalitygap
LOW
INCOME
HIGH
INCOME
100%
Facet 3: The Opportunity to Survive
Should Not, but Is Defined by Income
In Canada, almost 90% of children with
leukemia survive.
In the poorest countries only 10%.
Facet 5: The most insidious injustice
is lack of access to pain control
Non-methadone, Morphine Equivalent opioid
consumption per death from HIV or cancer in pain:
Poorest 10%: 54 mg per death
Richest 10%: 97,400 mg per death
"  Mirrors the overall epidemiological
transition
"   LMICs increasingly face both infection-
associated cancers, and all other cancers.
The Cancer Transition
"   Cancers increasingly only of the poor, are
not the only cancers affecting the poor.
LMICs account for
>90% of cervical
cancer deaths and
>60% of breast
cancer deaths. Both
are leading killers –
especially of young
women.
Did you know?????
The second or third most common
cause of death, especially among
young women?
In LAC, BC is:	
  
The cancer transition:
women
0	
  
4	
  
8	
  
12	
  
16	
  
2010	
  1955	
  
Mexico: cervical cancer.
Women and mothers in LMICs
face many risks through the life cycle
Women 15-59, annual deaths
Diabetes
120,889
Breast
cancer
166,577
Source: Estimates based on data from WHO: Global Health Observatory, 2008 and Murray et al Lancet 2011.
Cervical
cancer
142,744
Mortality
in
childbirth
342,900
- 35%
in 30
years
= 430, 210 deaths
Investing In CCC:
We Cannot Afford Not To
"   Total economic cost of cancer, 2010: 2-4% of global GDP
"   Tobacco is a huge economic risk: 3.6% lower GDP
"   Inaction reduces efficacy of health and social investments
Prevention and treatment offers potential
world savings of $ US 130-940 billion
1/3-1/2 of cancer deaths are “avoidable”:
2.4-3.7 million deaths,
of which 80% are in LIMCs and women
✓	
  
The Diagonal Approach to
Health System Strengthening
"   Rather than focusing on either disease-specific
vertical or horizontal-systemic programs, harness
synergies that provide opportunities to tackle disease-
specific priorities while addressing systemic gaps and
optimize available resources
"   Diagonal strategies:  X = > Σ parts
"   Bridge disease divides: patients suffer over a lifetime, most
of it chronic.
"   Generate positive externalities: e.g. women’s cancer
programs also combat gender discrimination; access to pain
control supports surgery platforms
The costs to close the cancer divide
may be less than many fear:
"   All but 3 of 29 LMIC priority cancer agents are off-patent
"   Pain medication is cheap
"   Prices drop: HepB and HPV vaccines
"   Delivery & financing platforms & innovations are
underutilized, undeveloped, purchasing is fragmented,
procurement is unstable
Pink	
  Ribbon	
  Red	
  Ribbon-­‐	
  a	
  diagonal	
  ini3a3ve	
  
Global	
  Paediatric	
  Financing	
  En3ty	
  
PAHO	
  Strategic	
  Fund:	
  includes	
  NCDs,	
  2012	
  	
  
Pink	
  Ribbon	
  Red	
  Ribbon:	
  diagonal	
  partnership	
  
‘Diagonalizing’ Domestic
Financing:
Integrate cancer care and control into
national insurance and social security
programs to express previously suppressed
demand beginning with cancers of women
and children:
"  Mexico, Colombia, Dom Rep, Peru
"  China, India, Thailand
"  Rwanda, Ghana, South Africa
Universal Health Coverage in Mexico
through Seguro Popular
Horizontal	
  Coverage:	
  	
  
>	
  54.6	
  million	
  Beneficiaries	
  
Ver3cal	
  Coverage	
  	
  	
  
Diseases	
  and	
  Interven3ons:	
  	
  
	
  Expanded	
  Benefit	
  Package	
  	
  	
  
Seguro Popular: cancer
"   Accelerated, universal, vertical coverage by disease
with an effective package of interventions
"   2005: Cervical cancer
"   2006: ALL in children
"   2007: All pediatric cancers; Breast cancer
"   2011: Testicular and Prostate cancer and NHL
"   2012: Colorectal cancer
Evidence of impact:
"   Breast cancer adherence to treatment:
"   INCAN:
"   2005: 200/600
"   2010: 10/900
% diagnosed in Stage 4 by state
• # 2 killer of women 30-54
• Only 5-10% of cases in Mexico are
detected in Stage 1 or in situ
• Poor municipalites: 50% Stage 4; 5x rich
Delivery failure: Breast Cancer
Juanita
Poor/Marginalized	
  
Effective financial coverage requires
attention to the chronicity of illness
Breast cancer and Seguro Popular
–  Primary prevention
–  Secondary prevention (early detection)
–  Diagnosis
–  Treatment
–  Survivorship care
–  Palliative care
Harness platforms by integrating breast and
cervical cancer prevention, screening and
survivorship care into MCH, SRH, HIV/AIDS,
social welfare and anti-poverty programs.
Solution:
‘Diagonalizing’ Delivery
Examples:
•  Integration of breast and
cervical cancer awareness
and screening into the
national anti-poverty
program Oportunidades
Results: 000´s promoters, nurses, doctors
Harnessing the primary level of care
Where are the opportunities?
•  LMICs – not months but whole lifetimes to be gained
•  Focus on prevention but do not stop there!
–  No prevent/treat dichotomization
•  Do not take prices as fixed or given – price permeability
•  Harness global and national health system platforms
•  Redefine and reformulate health systems to manage chronicity
•  Innovate in implementation, delivery and financing
–  Evaluate, replicate and scale up
–  Leapfrog and give forward
•  Harness cancer to strengthen health and social systems
•  Recognize LMICs as part of a global solution:
 investment in learning, research and human beings
Expanding access to cancer care and control in
LMICs: Should, Could, and Can be done
From anecdote …
… to evidence

More Related Content

What's hot

Transition from film to digital mammography
Transition from film to digital mammographyTransition from film to digital mammography
Transition from film to digital mammographyLisanne van Lier
 
US Ethnicity and Cancer, Learning from the World (B Blauvelt Innovara)
US Ethnicity and Cancer, Learning from the World (B Blauvelt Innovara)US Ethnicity and Cancer, Learning from the World (B Blauvelt Innovara)
US Ethnicity and Cancer, Learning from the World (B Blauvelt Innovara)
Innovara, Inc.
 
Where is the C in HSS Framework? PAHO/WHO Perspective_ Del Riego
Where is the C in HSS Framework? PAHO/WHO Perspective_ Del RiegoWhere is the C in HSS Framework? PAHO/WHO Perspective_ Del Riego
Where is the C in HSS Framework? PAHO/WHO Perspective_ Del Riego
CORE Group
 
FINAL cervical cancer prevention mapping 2015
FINAL cervical cancer prevention mapping 2015FINAL cervical cancer prevention mapping 2015
FINAL cervical cancer prevention mapping 2015Melani Montano
 
Biotechnology: Novel Insights in Cancer Therapy
Biotechnology: Novel Insights in Cancer TherapyBiotechnology: Novel Insights in Cancer Therapy
Biotechnology: Novel Insights in Cancer Therapy
Taha A. Taha
 
Core gender info_note_en
Core gender info_note_enCore gender info_note_en
Core gender info_note_enclac.cab
 
Aharona glatman freedman social determinants sept 4-5 2013 -
Aharona glatman freedman social determinants sept 4-5 2013 -Aharona glatman freedman social determinants sept 4-5 2013 -
Aharona glatman freedman social determinants sept 4-5 2013 -Rosella Anstine
 
Risk Reduction Strategies for Breast-Cancer Related Lymphedema in Democratic ...
Risk Reduction Strategies for Breast-Cancer Related Lymphedema in Democratic ...Risk Reduction Strategies for Breast-Cancer Related Lymphedema in Democratic ...
Risk Reduction Strategies for Breast-Cancer Related Lymphedema in Democratic ...
CrimsonPublishers-PRM
 
Awareness Session On Antimicrobial resistance “Antimicrobials: Spread Awaren...
Awareness Session On Antimicrobial resistance  “Antimicrobials: Spread Awaren...Awareness Session On Antimicrobial resistance  “Antimicrobials: Spread Awaren...
Awareness Session On Antimicrobial resistance “Antimicrobials: Spread Awaren...
Nimra zaman
 
Global goal setting: a pathway to results 2.5 x 2025
Global goal setting: a pathway to results 2.5 x 2025Global goal setting: a pathway to results 2.5 x 2025
Global goal setting: a pathway to results 2.5 x 2025
Fundación Mexicana para la Salud A.C.
 
Ghia foundation strategy document v4.dec.17.2015 (ab)
Ghia foundation strategy document v4.dec.17.2015 (ab)Ghia foundation strategy document v4.dec.17.2015 (ab)
Ghia foundation strategy document v4.dec.17.2015 (ab)
Ghia Foundation
 
Cervical cancer
Cervical cancerCervical cancer
Cervical cancer
Noel Christian
 
Increased breast cancer survival differentials by race in America: Historic o...
Increased breast cancer survival differentials by race in America: Historic o...Increased breast cancer survival differentials by race in America: Historic o...
Increased breast cancer survival differentials by race in America: Historic o...
Cross-Validation & Knowledge Translation
 
Lymphatic Filariasis Winnable Battle presentation
Lymphatic Filariasis Winnable Battle presentationLymphatic Filariasis Winnable Battle presentation
Lymphatic Filariasis Winnable Battle presentationPublicHealthFoundation
 
The Global Burden of Disease (GBD) study
The Global Burden of Disease (GBD) studyThe Global Burden of Disease (GBD) study
The Global Burden of Disease (GBD) study
Δρ. Γιώργος K. Κασάπης
 
Global Facts And Figures 2007 Rev2
Global Facts And Figures 2007 Rev2Global Facts And Figures 2007 Rev2
Global Facts And Figures 2007 Rev2
Andrew Kwami
 
Cancer Gdsj091 Final
Cancer Gdsj091 FinalCancer Gdsj091 Final
Cancer Gdsj091 FinalAndrew Kwami
 

What's hot (20)

Transition from film to digital mammography
Transition from film to digital mammographyTransition from film to digital mammography
Transition from film to digital mammography
 
US Ethnicity and Cancer, Learning from the World (B Blauvelt Innovara)
US Ethnicity and Cancer, Learning from the World (B Blauvelt Innovara)US Ethnicity and Cancer, Learning from the World (B Blauvelt Innovara)
US Ethnicity and Cancer, Learning from the World (B Blauvelt Innovara)
 
Where is the C in HSS Framework? PAHO/WHO Perspective_ Del Riego
Where is the C in HSS Framework? PAHO/WHO Perspective_ Del RiegoWhere is the C in HSS Framework? PAHO/WHO Perspective_ Del Riego
Where is the C in HSS Framework? PAHO/WHO Perspective_ Del Riego
 
FINAL cervical cancer prevention mapping 2015
FINAL cervical cancer prevention mapping 2015FINAL cervical cancer prevention mapping 2015
FINAL cervical cancer prevention mapping 2015
 
Global Health Catalyst Cancer Summit at Harvard V7
Global Health Catalyst Cancer Summit at Harvard V7Global Health Catalyst Cancer Summit at Harvard V7
Global Health Catalyst Cancer Summit at Harvard V7
 
Biotechnology: Novel Insights in Cancer Therapy
Biotechnology: Novel Insights in Cancer TherapyBiotechnology: Novel Insights in Cancer Therapy
Biotechnology: Novel Insights in Cancer Therapy
 
Core gender info_note_en
Core gender info_note_enCore gender info_note_en
Core gender info_note_en
 
Aharona glatman freedman social determinants sept 4-5 2013 -
Aharona glatman freedman social determinants sept 4-5 2013 -Aharona glatman freedman social determinants sept 4-5 2013 -
Aharona glatman freedman social determinants sept 4-5 2013 -
 
Risk Reduction Strategies for Breast-Cancer Related Lymphedema in Democratic ...
Risk Reduction Strategies for Breast-Cancer Related Lymphedema in Democratic ...Risk Reduction Strategies for Breast-Cancer Related Lymphedema in Democratic ...
Risk Reduction Strategies for Breast-Cancer Related Lymphedema in Democratic ...
 
Awareness Session On Antimicrobial resistance “Antimicrobials: Spread Awaren...
Awareness Session On Antimicrobial resistance  “Antimicrobials: Spread Awaren...Awareness Session On Antimicrobial resistance  “Antimicrobials: Spread Awaren...
Awareness Session On Antimicrobial resistance “Antimicrobials: Spread Awaren...
 
D.ompad
D.ompadD.ompad
D.ompad
 
Global goal setting: a pathway to results 2.5 x 2025
Global goal setting: a pathway to results 2.5 x 2025Global goal setting: a pathway to results 2.5 x 2025
Global goal setting: a pathway to results 2.5 x 2025
 
Ghia foundation strategy document v4.dec.17.2015 (ab)
Ghia foundation strategy document v4.dec.17.2015 (ab)Ghia foundation strategy document v4.dec.17.2015 (ab)
Ghia foundation strategy document v4.dec.17.2015 (ab)
 
Cervical cancer
Cervical cancerCervical cancer
Cervical cancer
 
HIV Winnable Battle presentation
HIV Winnable Battle presentationHIV Winnable Battle presentation
HIV Winnable Battle presentation
 
Increased breast cancer survival differentials by race in America: Historic o...
Increased breast cancer survival differentials by race in America: Historic o...Increased breast cancer survival differentials by race in America: Historic o...
Increased breast cancer survival differentials by race in America: Historic o...
 
Lymphatic Filariasis Winnable Battle presentation
Lymphatic Filariasis Winnable Battle presentationLymphatic Filariasis Winnable Battle presentation
Lymphatic Filariasis Winnable Battle presentation
 
The Global Burden of Disease (GBD) study
The Global Burden of Disease (GBD) studyThe Global Burden of Disease (GBD) study
The Global Burden of Disease (GBD) study
 
Global Facts And Figures 2007 Rev2
Global Facts And Figures 2007 Rev2Global Facts And Figures 2007 Rev2
Global Facts And Figures 2007 Rev2
 
Cancer Gdsj091 Final
Cancer Gdsj091 FinalCancer Gdsj091 Final
Cancer Gdsj091 Final
 

Similar to Closing the cancer divide for women: An opportunity of lifetimes Women´s Cancer Initiative

Demystifying Cervical Cancer.pdf
Demystifying Cervical Cancer.pdfDemystifying Cervical Cancer.pdf
Demystifying Cervical Cancer.pdf
Lija Mary Mathew
 
ABC1 - M. Mayer - Keynote lecture: Living with the Advanced Breast Cancer: Ch...
ABC1 - M. Mayer - Keynote lecture: Living with the Advanced Breast Cancer: Ch...ABC1 - M. Mayer - Keynote lecture: Living with the Advanced Breast Cancer: Ch...
ABC1 - M. Mayer - Keynote lecture: Living with the Advanced Breast Cancer: Ch...European School of Oncology
 
Câncer, uma prioridade global - Gilberto Lopes
Câncer, uma prioridade global - Gilberto Lopes Câncer, uma prioridade global - Gilberto Lopes
Câncer, uma prioridade global - Gilberto Lopes
Oncoguia
 
Closing the cancer divide for women: Part 1
Closing the cancer divide for women: Part 1Closing the cancer divide for women: Part 1
Closing the cancer divide for women: Part 1
Fundación Mexicana para la Salud A.C.
 
Living with Advanced Breast Cancer: Challenges and Opportunities
Living with Advanced Breast Cancer: Challenges and OpportunitiesLiving with Advanced Breast Cancer: Challenges and Opportunities
Living with Advanced Breast Cancer: Challenges and Opportunities
bkling
 
Bridging Clinical Gaps and Disparities in Care in TNBC
Bridging Clinical Gaps and Disparities in Care in TNBCBridging Clinical Gaps and Disparities in Care in TNBC
Bridging Clinical Gaps and Disparities in Care in TNBC
bkling
 
Susan G. Komen for the Cure Presentation at Partnering for Cures
Susan G. Komen for the Cure Presentation at Partnering for CuresSusan G. Komen for the Cure Presentation at Partnering for Cures
Susan G. Komen for the Cure Presentation at Partnering for Cures
TRAIN Central Station
 
The MDG for HIV/AIDS, malaria and other diseases: can rhetoric become reality?
The MDG for HIV/AIDS, malaria and other diseases: can rhetoric become reality?The MDG for HIV/AIDS, malaria and other diseases: can rhetoric become reality?
The MDG for HIV/AIDS, malaria and other diseases: can rhetoric become reality?
cmaverga
 
Running head INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS1.docx
Running head INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS1.docxRunning head INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS1.docx
Running head INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS1.docx
cowinhelen
 
Evidence Based Guide of Screening for Prevention of Cervical Cancer
Evidence Based Guide of Screening for Prevention of Cervical Cancer  Evidence Based Guide of Screening for Prevention of Cervical Cancer
Evidence Based Guide of Screening for Prevention of Cervical Cancer
Lifecare Centre
 
Building Bridges Program Overview 030116
Building Bridges Program Overview 030116Building Bridges Program Overview 030116
Building Bridges Program Overview 030116Evangeline Baker
 
From surviving to thriving: cancer’s next challenge
From surviving to thriving: cancer’s next challengeFrom surviving to thriving: cancer’s next challenge
From surviving to thriving: cancer’s next challenge
PwC Russia
 
Breast cancer epidemiology
Breast cancer epidemiology Breast cancer epidemiology
Breast cancer epidemiology
abdulaziz muslim
 
Improving Women's Reproductive Health Through Expanding Access to Key Health ...
Improving Women's Reproductive Health Through Expanding Access to Key Health ...Improving Women's Reproductive Health Through Expanding Access to Key Health ...
Improving Women's Reproductive Health Through Expanding Access to Key Health ...
The Bixby Center on Population and Reproductive Health
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Women's Access to Healthcare - GRU Cancer Center Presentation
Women's Access to Healthcare - GRU Cancer Center PresentationWomen's Access to Healthcare - GRU Cancer Center Presentation
Women's Access to Healthcare - GRU Cancer Center Presentation
Georgia Commission on Women
 
Breast cancer
Breast cancerBreast cancer
Breast cancer
Rehab India Foundation
 
breast cancer awarness.pptx
breast cancer awarness.pptxbreast cancer awarness.pptx
breast cancer awarness.pptx
Maha Hafez
 
'Cancer' class for UG 6th sem
'Cancer' class for UG 6th sem'Cancer' class for UG 6th sem
'Cancer' class for UG 6th sem
Dr.Kuntala Ray
 

Similar to Closing the cancer divide for women: An opportunity of lifetimes Women´s Cancer Initiative (20)

Demystifying Cervical Cancer.pdf
Demystifying Cervical Cancer.pdfDemystifying Cervical Cancer.pdf
Demystifying Cervical Cancer.pdf
 
ABC1 - M. Mayer - Keynote lecture: Living with the Advanced Breast Cancer: Ch...
ABC1 - M. Mayer - Keynote lecture: Living with the Advanced Breast Cancer: Ch...ABC1 - M. Mayer - Keynote lecture: Living with the Advanced Breast Cancer: Ch...
ABC1 - M. Mayer - Keynote lecture: Living with the Advanced Breast Cancer: Ch...
 
Câncer, uma prioridade global - Gilberto Lopes
Câncer, uma prioridade global - Gilberto Lopes Câncer, uma prioridade global - Gilberto Lopes
Câncer, uma prioridade global - Gilberto Lopes
 
Closing the cancer divide for women: Part 1
Closing the cancer divide for women: Part 1Closing the cancer divide for women: Part 1
Closing the cancer divide for women: Part 1
 
Living with Advanced Breast Cancer: Challenges and Opportunities
Living with Advanced Breast Cancer: Challenges and OpportunitiesLiving with Advanced Breast Cancer: Challenges and Opportunities
Living with Advanced Breast Cancer: Challenges and Opportunities
 
Bridging Clinical Gaps and Disparities in Care in TNBC
Bridging Clinical Gaps and Disparities in Care in TNBCBridging Clinical Gaps and Disparities in Care in TNBC
Bridging Clinical Gaps and Disparities in Care in TNBC
 
Susan G. Komen for the Cure Presentation at Partnering for Cures
Susan G. Komen for the Cure Presentation at Partnering for CuresSusan G. Komen for the Cure Presentation at Partnering for Cures
Susan G. Komen for the Cure Presentation at Partnering for Cures
 
The MDG for HIV/AIDS, malaria and other diseases: can rhetoric become reality?
The MDG for HIV/AIDS, malaria and other diseases: can rhetoric become reality?The MDG for HIV/AIDS, malaria and other diseases: can rhetoric become reality?
The MDG for HIV/AIDS, malaria and other diseases: can rhetoric become reality?
 
Running head INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS1.docx
Running head INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS1.docxRunning head INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS1.docx
Running head INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS1.docx
 
Cancer.pdf
Cancer.pdfCancer.pdf
Cancer.pdf
 
Evidence Based Guide of Screening for Prevention of Cervical Cancer
Evidence Based Guide of Screening for Prevention of Cervical Cancer  Evidence Based Guide of Screening for Prevention of Cervical Cancer
Evidence Based Guide of Screening for Prevention of Cervical Cancer
 
Building Bridges Program Overview 030116
Building Bridges Program Overview 030116Building Bridges Program Overview 030116
Building Bridges Program Overview 030116
 
From surviving to thriving: cancer’s next challenge
From surviving to thriving: cancer’s next challengeFrom surviving to thriving: cancer’s next challenge
From surviving to thriving: cancer’s next challenge
 
Breast cancer epidemiology
Breast cancer epidemiology Breast cancer epidemiology
Breast cancer epidemiology
 
Improving Women's Reproductive Health Through Expanding Access to Key Health ...
Improving Women's Reproductive Health Through Expanding Access to Key Health ...Improving Women's Reproductive Health Through Expanding Access to Key Health ...
Improving Women's Reproductive Health Through Expanding Access to Key Health ...
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Women's Access to Healthcare - GRU Cancer Center Presentation
Women's Access to Healthcare - GRU Cancer Center PresentationWomen's Access to Healthcare - GRU Cancer Center Presentation
Women's Access to Healthcare - GRU Cancer Center Presentation
 
Breast cancer
Breast cancerBreast cancer
Breast cancer
 
breast cancer awarness.pptx
breast cancer awarness.pptxbreast cancer awarness.pptx
breast cancer awarness.pptx
 
'Cancer' class for UG 6th sem
'Cancer' class for UG 6th sem'Cancer' class for UG 6th sem
'Cancer' class for UG 6th sem
 

More from Fundación Mexicana para la Salud A.C.

Comité técnico asesor. perspectivas 2030 121015.5
Comité técnico asesor. perspectivas 2030 121015.5Comité técnico asesor. perspectivas 2030 121015.5
Comité técnico asesor. perspectivas 2030 121015.5
Fundación Mexicana para la Salud A.C.
 
Propuesta de FUNSALUD para la Universalidad de los Servicios de Salud. Modelo...
Propuesta de FUNSALUD para la Universalidad de los Servicios de Salud. Modelo...Propuesta de FUNSALUD para la Universalidad de los Servicios de Salud. Modelo...
Propuesta de FUNSALUD para la Universalidad de los Servicios de Salud. Modelo...
Fundación Mexicana para la Salud A.C.
 
Funsalud Jornadas GEA
Funsalud Jornadas GEAFunsalud Jornadas GEA
Presentación Unversalidad de los servicios de Salud
Presentación Unversalidad de los servicios de SaludPresentación Unversalidad de los servicios de Salud
Presentación Unversalidad de los servicios de Salud
Fundación Mexicana para la Salud A.C.
 
Universalidad de Servicios de Salud, Propuesta de FUNSALUD
Universalidad de Servicios de Salud, Propuesta de FUNSALUDUniversalidad de Servicios de Salud, Propuesta de FUNSALUD
Universalidad de Servicios de Salud, Propuesta de FUNSALUD
Fundación Mexicana para la Salud A.C.
 
Perspectivas del Sector Privado
Perspectivas del Sector PrivadoPerspectivas del Sector Privado
Perspectivas del Sector Privado
Fundación Mexicana para la Salud A.C.
 
Universalidad de los servicios de Salud. Propuesta de FUNSALUD
Universalidad de los servicios de Salud. Propuesta de FUNSALUDUniversalidad de los servicios de Salud. Propuesta de FUNSALUD
Universalidad de los servicios de Salud. Propuesta de FUNSALUD
Fundación Mexicana para la Salud A.C.
 
Cobertura universal efectiva en México: El acceso al control del dolor y los ...
Cobertura universal efectiva en México: El acceso al control del dolor y los ...Cobertura universal efectiva en México: El acceso al control del dolor y los ...
Cobertura universal efectiva en México: El acceso al control del dolor y los ...
Fundación Mexicana para la Salud A.C.
 
El futuro de la salud privada en México
El futuro de la salud privada en MéxicoEl futuro de la salud privada en México
El futuro de la salud privada en México
Fundación Mexicana para la Salud A.C.
 
La Oferta Pública de la Metadona en México
La Oferta Pública de la Metadona en MéxicoLa Oferta Pública de la Metadona en México
La Oferta Pública de la Metadona en México
Fundación Mexicana para la Salud A.C.
 
Política farmacéutica y priorización en salud
Política farmacéutica y priorización en saludPolítica farmacéutica y priorización en salud
Política farmacéutica y priorización en salud
Fundación Mexicana para la Salud A.C.
 
Servicios de salud universales
Servicios de salud universalesServicios de salud universales
Servicios de salud universales
Fundación Mexicana para la Salud A.C.
 
El papel de FUNSALUD en la innovación genómica en México
El papel de FUNSALUD en la innovación genómica en MéxicoEl papel de FUNSALUD en la innovación genómica en México
El papel de FUNSALUD en la innovación genómica en México
Fundación Mexicana para la Salud A.C.
 
Proyecto “Fortalecimiento de las estrategias nacionales de prevención y reduc...
Proyecto “Fortalecimiento de las estrategias nacionales de prevención y reduc...Proyecto “Fortalecimiento de las estrategias nacionales de prevención y reduc...
Proyecto “Fortalecimiento de las estrategias nacionales de prevención y reduc...
Fundación Mexicana para la Salud A.C.
 
El futuro del Sistema Mexicano de Salud
El futuro del Sistema Mexicano de SaludEl futuro del Sistema Mexicano de Salud
El futuro del Sistema Mexicano de Salud
Fundación Mexicana para la Salud A.C.
 
Universalidad de los servicios de salud. La propuesta FUNSALUD
Universalidad de los servicios de salud. La propuesta FUNSALUDUniversalidad de los servicios de salud. La propuesta FUNSALUD
Universalidad de los servicios de salud. La propuesta FUNSALUD
Fundación Mexicana para la Salud A.C.
 
Retos legales y económicos del Sistema Nacional de Salud
Retos legales y económicos del Sistema Nacional de SaludRetos legales y económicos del Sistema Nacional de Salud
Retos legales y económicos del Sistema Nacional de Salud
Fundación Mexicana para la Salud A.C.
 
FUNSALUD en el diálogo sobre diabetes en México
FUNSALUD en el diálogo sobre diabetes en MéxicoFUNSALUD en el diálogo sobre diabetes en México
FUNSALUD en el diálogo sobre diabetes en México
Fundación Mexicana para la Salud A.C.
 
¿Qué hacer con el niño con obesidad?, una visión psicodinámica.
¿Qué hacer con el niño con obesidad?, una visión psicodinámica.¿Qué hacer con el niño con obesidad?, una visión psicodinámica.
¿Qué hacer con el niño con obesidad?, una visión psicodinámica.
Fundación Mexicana para la Salud A.C.
 

More from Fundación Mexicana para la Salud A.C. (20)

Comité técnico asesor. perspectivas 2030 121015.5
Comité técnico asesor. perspectivas 2030 121015.5Comité técnico asesor. perspectivas 2030 121015.5
Comité técnico asesor. perspectivas 2030 121015.5
 
Propuesta de FUNSALUD para la Universalidad de los Servicios de Salud. Modelo...
Propuesta de FUNSALUD para la Universalidad de los Servicios de Salud. Modelo...Propuesta de FUNSALUD para la Universalidad de los Servicios de Salud. Modelo...
Propuesta de FUNSALUD para la Universalidad de los Servicios de Salud. Modelo...
 
Funsalud Jornadas GEA
Funsalud Jornadas GEAFunsalud Jornadas GEA
Funsalud Jornadas GEA
 
Presentación Unversalidad de los servicios de Salud
Presentación Unversalidad de los servicios de SaludPresentación Unversalidad de los servicios de Salud
Presentación Unversalidad de los servicios de Salud
 
Universalidad de Servicios de Salud, Propuesta de FUNSALUD
Universalidad de Servicios de Salud, Propuesta de FUNSALUDUniversalidad de Servicios de Salud, Propuesta de FUNSALUD
Universalidad de Servicios de Salud, Propuesta de FUNSALUD
 
Universalidad de Servicios de Salud, Propuesta de FUNSALUD
Universalidad de Servicios de Salud, Propuesta de FUNSALUDUniversalidad de Servicios de Salud, Propuesta de FUNSALUD
Universalidad de Servicios de Salud, Propuesta de FUNSALUD
 
Perspectivas del Sector Privado
Perspectivas del Sector PrivadoPerspectivas del Sector Privado
Perspectivas del Sector Privado
 
Universalidad de los servicios de Salud. Propuesta de FUNSALUD
Universalidad de los servicios de Salud. Propuesta de FUNSALUDUniversalidad de los servicios de Salud. Propuesta de FUNSALUD
Universalidad de los servicios de Salud. Propuesta de FUNSALUD
 
Cobertura universal efectiva en México: El acceso al control del dolor y los ...
Cobertura universal efectiva en México: El acceso al control del dolor y los ...Cobertura universal efectiva en México: El acceso al control del dolor y los ...
Cobertura universal efectiva en México: El acceso al control del dolor y los ...
 
El futuro de la salud privada en México
El futuro de la salud privada en MéxicoEl futuro de la salud privada en México
El futuro de la salud privada en México
 
La Oferta Pública de la Metadona en México
La Oferta Pública de la Metadona en MéxicoLa Oferta Pública de la Metadona en México
La Oferta Pública de la Metadona en México
 
Política farmacéutica y priorización en salud
Política farmacéutica y priorización en saludPolítica farmacéutica y priorización en salud
Política farmacéutica y priorización en salud
 
Servicios de salud universales
Servicios de salud universalesServicios de salud universales
Servicios de salud universales
 
El papel de FUNSALUD en la innovación genómica en México
El papel de FUNSALUD en la innovación genómica en MéxicoEl papel de FUNSALUD en la innovación genómica en México
El papel de FUNSALUD en la innovación genómica en México
 
Proyecto “Fortalecimiento de las estrategias nacionales de prevención y reduc...
Proyecto “Fortalecimiento de las estrategias nacionales de prevención y reduc...Proyecto “Fortalecimiento de las estrategias nacionales de prevención y reduc...
Proyecto “Fortalecimiento de las estrategias nacionales de prevención y reduc...
 
El futuro del Sistema Mexicano de Salud
El futuro del Sistema Mexicano de SaludEl futuro del Sistema Mexicano de Salud
El futuro del Sistema Mexicano de Salud
 
Universalidad de los servicios de salud. La propuesta FUNSALUD
Universalidad de los servicios de salud. La propuesta FUNSALUDUniversalidad de los servicios de salud. La propuesta FUNSALUD
Universalidad de los servicios de salud. La propuesta FUNSALUD
 
Retos legales y económicos del Sistema Nacional de Salud
Retos legales y económicos del Sistema Nacional de SaludRetos legales y económicos del Sistema Nacional de Salud
Retos legales y económicos del Sistema Nacional de Salud
 
FUNSALUD en el diálogo sobre diabetes en México
FUNSALUD en el diálogo sobre diabetes en MéxicoFUNSALUD en el diálogo sobre diabetes en México
FUNSALUD en el diálogo sobre diabetes en México
 
¿Qué hacer con el niño con obesidad?, una visión psicodinámica.
¿Qué hacer con el niño con obesidad?, una visión psicodinámica.¿Qué hacer con el niño con obesidad?, una visión psicodinámica.
¿Qué hacer con el niño con obesidad?, una visión psicodinámica.
 

Recently uploaded

ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 

Recently uploaded (20)

ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 

Closing the cancer divide for women: An opportunity of lifetimes Women´s Cancer Initiative

  • 1.
  • 3.
  • 4. From anecdote … … to evidence
  • 6. GTF.CCC: Mission and Vision •  design, participate in implementation, and evaluate innovative strategies for expanding access to cancer prevention, detection and care that provide local and cross-country evidence for scaling up access to cancer care and control, and strengthening health systems in LMICs. •  facilitate action through the production of new knowledge and through multi-stakeholder frameworks and partnerships that demonstrate effective models of care that can be replicated and scaled up in LMICs.
  • 7. = global health + cancer care
  • 8. Abish Romeo, México Drew G. Faust President of Harvard University 22+ year BC survivor
  • 9.
  • 10. Closing the Cancer Divide: An Equity Imperative I: Should be done II: Could be done III: Can be done M1. Unnecessary M2. Unaffordable M3. Impossible M4: Inappropriate Expanding access to cancer care and control in LMICs: 1: Innovative Delivery 2: Access: Affordable Med’s, Vaccines & Tech’s 3: Innovative Financing: Domestic and Global 4: Evidence for Decision-Making 5: Stewardship and Leadership
  • 11. Cancer is a disease of both rich and poor but the poor suffer even more: 1.  Exposure to risk factors 2.  Preventable cancers (infection) 3.  Treatable cancer death and disability 4.  Stigma and discrimination 5.  Avoidable pain and suffering Closing the Cancer Divide is an Equity Imperative Facets
  • 12. Adults Leukaemia All cancers Source: Knaul, Arreola, Mendez. estimates based on IARC, Globocan, 2010. Children LOW INCOME HIGH INCOME Survival inequalitygap LOW INCOME HIGH INCOME 100% Facet 3: The Opportunity to Survive Should Not, but Is Defined by Income In Canada, almost 90% of children with leukemia survive. In the poorest countries only 10%.
  • 13. Facet 5: The most insidious injustice is lack of access to pain control Non-methadone, Morphine Equivalent opioid consumption per death from HIV or cancer in pain: Poorest 10%: 54 mg per death Richest 10%: 97,400 mg per death
  • 14. "  Mirrors the overall epidemiological transition "   LMICs increasingly face both infection- associated cancers, and all other cancers. The Cancer Transition "   Cancers increasingly only of the poor, are not the only cancers affecting the poor.
  • 15. LMICs account for >90% of cervical cancer deaths and >60% of breast cancer deaths. Both are leading killers – especially of young women. Did you know????? The second or third most common cause of death, especially among young women? In LAC, BC is:   The cancer transition: women 0   4   8   12   16   2010  1955   Mexico: cervical cancer.
  • 16. Women and mothers in LMICs face many risks through the life cycle Women 15-59, annual deaths Diabetes 120,889 Breast cancer 166,577 Source: Estimates based on data from WHO: Global Health Observatory, 2008 and Murray et al Lancet 2011. Cervical cancer 142,744 Mortality in childbirth 342,900 - 35% in 30 years = 430, 210 deaths
  • 17. Investing In CCC: We Cannot Afford Not To "   Total economic cost of cancer, 2010: 2-4% of global GDP "   Tobacco is a huge economic risk: 3.6% lower GDP "   Inaction reduces efficacy of health and social investments Prevention and treatment offers potential world savings of $ US 130-940 billion 1/3-1/2 of cancer deaths are “avoidable”: 2.4-3.7 million deaths, of which 80% are in LIMCs and women ✓  
  • 18. The Diagonal Approach to Health System Strengthening "   Rather than focusing on either disease-specific vertical or horizontal-systemic programs, harness synergies that provide opportunities to tackle disease- specific priorities while addressing systemic gaps and optimize available resources "   Diagonal strategies:  X = > Σ parts "   Bridge disease divides: patients suffer over a lifetime, most of it chronic. "   Generate positive externalities: e.g. women’s cancer programs also combat gender discrimination; access to pain control supports surgery platforms
  • 19. The costs to close the cancer divide may be less than many fear: "   All but 3 of 29 LMIC priority cancer agents are off-patent "   Pain medication is cheap "   Prices drop: HepB and HPV vaccines "   Delivery & financing platforms & innovations are underutilized, undeveloped, purchasing is fragmented, procurement is unstable Pink  Ribbon  Red  Ribbon-­‐  a  diagonal  ini3a3ve   Global  Paediatric  Financing  En3ty   PAHO  Strategic  Fund:  includes  NCDs,  2012     Pink  Ribbon  Red  Ribbon:  diagonal  partnership  
  • 20. ‘Diagonalizing’ Domestic Financing: Integrate cancer care and control into national insurance and social security programs to express previously suppressed demand beginning with cancers of women and children: "  Mexico, Colombia, Dom Rep, Peru "  China, India, Thailand "  Rwanda, Ghana, South Africa
  • 21. Universal Health Coverage in Mexico through Seguro Popular Horizontal  Coverage:     >  54.6  million  Beneficiaries   Ver3cal  Coverage       Diseases  and  Interven3ons:      Expanded  Benefit  Package      
  • 22. Seguro Popular: cancer "   Accelerated, universal, vertical coverage by disease with an effective package of interventions "   2005: Cervical cancer "   2006: ALL in children "   2007: All pediatric cancers; Breast cancer "   2011: Testicular and Prostate cancer and NHL "   2012: Colorectal cancer Evidence of impact: "   Breast cancer adherence to treatment: "   INCAN: "   2005: 200/600 "   2010: 10/900
  • 23. % diagnosed in Stage 4 by state • # 2 killer of women 30-54 • Only 5-10% of cases in Mexico are detected in Stage 1 or in situ • Poor municipalites: 50% Stage 4; 5x rich Delivery failure: Breast Cancer Juanita Poor/Marginalized  
  • 24. Effective financial coverage requires attention to the chronicity of illness Breast cancer and Seguro Popular –  Primary prevention –  Secondary prevention (early detection) –  Diagnosis –  Treatment –  Survivorship care –  Palliative care
  • 25. Harness platforms by integrating breast and cervical cancer prevention, screening and survivorship care into MCH, SRH, HIV/AIDS, social welfare and anti-poverty programs. Solution: ‘Diagonalizing’ Delivery Examples: •  Integration of breast and cervical cancer awareness and screening into the national anti-poverty program Oportunidades Results: 000´s promoters, nurses, doctors Harnessing the primary level of care
  • 26. Where are the opportunities? •  LMICs – not months but whole lifetimes to be gained •  Focus on prevention but do not stop there! –  No prevent/treat dichotomization •  Do not take prices as fixed or given – price permeability •  Harness global and national health system platforms •  Redefine and reformulate health systems to manage chronicity •  Innovate in implementation, delivery and financing –  Evaluate, replicate and scale up –  Leapfrog and give forward •  Harness cancer to strengthen health and social systems •  Recognize LMICs as part of a global solution:  investment in learning, research and human beings
  • 27. Expanding access to cancer care and control in LMICs: Should, Could, and Can be done
  • 28. From anecdote … … to evidence